Tag Archives: first

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma

PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural… Read More »

FDA Approves Onureg (azacitidine tablets) as Continued Treatment for Adults in First Remission with Acute Myeloid Leukemia

FDA Approves Onureg (azacitidine tablets) as Continued Treatment for Adults in First Remission with Acute Myeloid Leukemia Print this page PRINCETON, N.J.–(BUSINESS WIRE) September 1, 2020 –Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Onureg (azacitidine 300 mg tablets, CC-486) for the continued treatment of adult… Read More »

First Stanford Medicine-Intermountain Healthcare fellows complete master’s program in health services – Stanford Medical Center Report

Email Tweet First Stanford Medicine-Intermountain Healthcare fellows complete master’s program in health services A master’s program in health services research, offered jointly by Stanford Medicine and Intermountain Healthcare, graduates its first two physician leaders. Aug 14 2020 The Stanford Medicine-Intermountain Fellowship in Population Health, Delivery Science and Primary Care prepares physicians to implement quality improvement… Read More »